LEP and metabolic dysfunction-associated steatotic liver disease: It is well known that adipocytokine leptin inhibits appetite and weight gain, yet leptin resistance (hyperleptinemia) is commonly observed in NAFLD individuals (Oswal and Yeo, 2010; Polyzos et al., 2015).